C

Cidara Therapeutics
D

CDTX

219.780
USD
0.09
(0.04%)
مغلق
حجم التداول
37,371
الربح لكل سهم
-8
العائد الربحي
-
P/E
-20
حجم السوق
6,911,269,133
أصول ذات صلة الأخبار المقالات

العنوان: Cidara Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.